Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based drug design

T L Blundell1

  • 1Department of Biochemistry, University of Cambridge, UK.

Nature
|November 7, 1996
PubMed
Summary
This summary is machine-generated.

Over 4,000 macromolecular structures are known, aiding drug design. This structural data provides a foundation for developing new therapeutics targeting key biological molecules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional and structural characterisation of RimL from Bacillus cereus, a new N<sup>α</sup>-acetyltransferase of ribosomal proteins that was wrongly assigned as an aminoglycosyltransferase.

International journal of biological macromolecules·2024
Same author

Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding.

Chemical science·2018
Same author

A three-dimensional model of the Photosystem II reaction centre of Pisum sativum.

Photosynthesis research·2014
Same author

An analysis of subdomain orientation, conformational change and disorder in relation to crystal packing of aspartic proteinases.

Acta crystallographica. Section D, Biological crystallography·2012
Same author

FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.

Journal of molecular endocrinology·2008
Same author

Quantifying structural and functional restraints on amino acid substitutions in evolution of proteins.

Biochemistry. Biokhimiia·2005
Same journal

Six ways to put the public at the heart of science and policy.

Nature·2026
Same journal

The complex truth about trust in science.

Nature·2026
Same journal

Have people stopped trusting science? The data tell a surprising story.

Nature·2026
Same journal

How FAIR data are helping to build trust in science.

Nature·2026
Same journal

Scientists should recognize their own political biases to build public trust.

Nature·2026
Same journal

Harmonizing standards and resources for the medical genome.

Nature·2026
See all related articles

Area of Science:

  • Structural biology
  • Drug discovery
  • Computational chemistry

Background:

  • The PDB contains over 4,000 solved macromolecular structures.
  • Macromolecules are crucial drug targets in various diseases.
  • Structural information is vital for rational drug design.

Purpose of the Study:

  • To highlight the growing importance of macromolecular structural data.
  • To emphasize the role of structural biology in modern drug discovery.
  • To showcase the utility of 3D structures in designing novel therapeutics.

Main Methods:

  • Data compilation from structural databases (e.g., PDB).
  • Analysis of structural data for drug target identification.
  • Application of structure-based drug design principles.

Related Experiment Videos

Main Results:

  • A significant and increasing repository of macromolecular structures is available.
  • Many solved structures represent key targets for therapeutic intervention.
  • 3D structural knowledge facilitates the design of new drugs.

Conclusions:

  • The wealth of structural data is a powerful resource for drug development.
  • Structure-based drug design is a viable and effective strategy.
  • Continued structural elucidation will accelerate the discovery of new medicines.